biznews.com5h
Pfizer pulls sickle cell drug oxbryta, raising safety concerns
Pfizer’s abrupt withdrawal of Oxbryta, a drug for sickle cell disease, has sent shockwaves through the medical community.
The Pharma Letter6h
The week in pharma: action, reaction and insight – week to September 27
Significant regulatory news last week included the US Food and Drug Administration (FDA) granting approval for Zevra ...
health.economictimes.indiatimes12h
Why gene therapy for sickle cell is slow to catch on with patients
Gene Therapy: "It is so new ... I wanted to see more success stories before I committed to it," said Davis, who is studying ...
Revolutionary sickle cell treatment providing hope and equity in action
The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard ...